WO2006026604A3 - Methods for promoting wound healing - Google Patents

Methods for promoting wound healing Download PDF

Info

Publication number
WO2006026604A3
WO2006026604A3 PCT/US2005/030798 US2005030798W WO2006026604A3 WO 2006026604 A3 WO2006026604 A3 WO 2006026604A3 US 2005030798 W US2005030798 W US 2005030798W WO 2006026604 A3 WO2006026604 A3 WO 2006026604A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
wound healing
promoting wound
disclosed
wounds
Prior art date
Application number
PCT/US2005/030798
Other languages
French (fr)
Other versions
WO2006026604A2 (en
Inventor
Eli Wilner
Mathew Cohen
Original Assignee
Advanced Viral Res Corp
Posner Sari
Eli Wilner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Viral Res Corp, Posner Sari, Eli Wilner filed Critical Advanced Viral Res Corp
Priority to JP2007530256A priority Critical patent/JP2008511652A/en
Priority to AU2005279921A priority patent/AU2005279921A1/en
Priority to CA002578212A priority patent/CA2578212A1/en
Priority to EP05795551A priority patent/EP1804817A4/en
Publication of WO2006026604A2 publication Critical patent/WO2006026604A2/en
Publication of WO2006026604A3 publication Critical patent/WO2006026604A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to methods for the promotion of wound healing. Specifically, methods for treating patients having wounds comprising administering the immunomodulator, Product R, are disclosed. Pharmaceutical compositions and kits comprising Product R, an additional medicament, and pharmaceutically acceptable carriers are also disclosed. The disclosed methods are useful for promoting wound healing for a wide variety of wounds, ulcers and burns.
PCT/US2005/030798 2004-08-27 2005-08-29 Methods for promoting wound healing WO2006026604A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2007530256A JP2008511652A (en) 2004-08-27 2005-08-29 How to promote wound healing
AU2005279921A AU2005279921A1 (en) 2004-08-27 2005-08-29 Methods for promoting wound healing
CA002578212A CA2578212A1 (en) 2004-08-27 2005-08-29 Methods for promoting wound healing
EP05795551A EP1804817A4 (en) 2004-08-27 2005-08-29 Methods for promoting wound healing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60532004P 2004-08-27 2004-08-27
US60/605,320 2004-08-27

Publications (2)

Publication Number Publication Date
WO2006026604A2 WO2006026604A2 (en) 2006-03-09
WO2006026604A3 true WO2006026604A3 (en) 2006-12-07

Family

ID=36000687

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/030798 WO2006026604A2 (en) 2004-08-27 2005-08-29 Methods for promoting wound healing

Country Status (5)

Country Link
EP (1) EP1804817A4 (en)
JP (1) JP2008511652A (en)
AU (1) AU2005279921A1 (en)
CA (1) CA2578212A1 (en)
WO (1) WO2006026604A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528098B2 (en) 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
BR112012007399A2 (en) * 2009-09-29 2016-08-09 United Technologies Ut Ag oral care composition, uses of human recombinant interleukin-1 and methods for reducing bad breath and for the treatment or prevention of periodontal disease.
AU2014253608B2 (en) * 2013-04-18 2018-06-07 QBiotics Pty Ltd Methods and compositions for wound healing
CN108339112B (en) * 2016-12-30 2023-04-21 亚宝药业集团股份有限公司 Nutritional composition for promoting wound healing, bedsore repair and postoperative stress ulcer healing

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807839A (en) * 1997-04-15 1998-09-15 Advanced Viral Research Corp. Method for stimulating red blood cell production
US5849196A (en) * 1996-10-07 1998-12-15 Immune Modulation Maximum Composition containing peptides and nucleic acids and methods of making same
US6303153B1 (en) * 1996-10-22 2001-10-16 Advanced Viral Research Corp. Preparation of a therapeutic composition
US6355226B1 (en) * 1997-04-15 2002-03-12 Advanced Viral Research Corp. Topical treatment of skin disease and eye afflictions
US20020107184A1 (en) * 1997-11-04 2002-08-08 Shalom Z. Hirschman Method for treating melanoma
US6528098B2 (en) * 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
US6670118B2 (en) * 1997-04-15 2003-12-30 Advanced Viral Research Corp. Method for treating papillomavirus infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902786A (en) * 1997-04-15 1999-05-11 Advanced Viral Research Corp. Treatment of basal cell carcinoma with product R, a peptide-nucleic acid preparation
US7439234B2 (en) * 1997-04-15 2008-10-21 Advanced Viral Research Corporation Method for treating cancer patients undergoing chemotherapy

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849196A (en) * 1996-10-07 1998-12-15 Immune Modulation Maximum Composition containing peptides and nucleic acids and methods of making same
US6303153B1 (en) * 1996-10-22 2001-10-16 Advanced Viral Research Corp. Preparation of a therapeutic composition
US6528098B2 (en) * 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
US20030158107A1 (en) * 1996-10-22 2003-08-21 Advanced Viral Research Corp. Preparation of a therapeutic composition
US5807839A (en) * 1997-04-15 1998-09-15 Advanced Viral Research Corp. Method for stimulating red blood cell production
US6355226B1 (en) * 1997-04-15 2002-03-12 Advanced Viral Research Corp. Topical treatment of skin disease and eye afflictions
US6670118B2 (en) * 1997-04-15 2003-12-30 Advanced Viral Research Corp. Method for treating papillomavirus infections
US20020107184A1 (en) * 1997-11-04 2002-08-08 Shalom Z. Hirschman Method for treating melanoma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1804817A4 *

Also Published As

Publication number Publication date
CA2578212A1 (en) 2006-03-09
EP1804817A2 (en) 2007-07-11
EP1804817A4 (en) 2009-11-11
JP2008511652A (en) 2008-04-17
WO2006026604A2 (en) 2006-03-09
AU2005279921A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
TW200640499A (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
WO2004045618A3 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
CY1107465T1 (en) MELAGATRANI FOR THERAPEUTIC INFECTION
HK1090843A1 (en) Pharmaceutical compositions for healing wounds
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
WO2004037789A3 (en) Methylene urea derivatives as raf-kinase inhibitors
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
HK1068606A1 (en) Novel aminobenzoephenones
WO2006026604A3 (en) Methods for promoting wound healing
HK1098352A1 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
ATE231849T1 (en) CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE
MXPA01010613A (en) Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions.
MXPA05001469A (en) Use of fermented wheat germ extract as anti-inflammatory agent.
WO2006091222A3 (en) Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118
HK1075390A1 (en) Citalopram for the treatment of elevated blood pressure
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
WO2010045529A3 (en) Combination therapies for the treatment of obesity
WO2006015183A3 (en) Pharmaceutical compositions for treating disorders of the skin
ATE252903T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CONVULSIVE CONDITIONS
DE60222662D1 (en) USE OF L-AZETYLCARNITINE FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTIVE POST-SURGERY PAIN TREATMENT
SE0202287D0 (en) New compounds
WO2004024132A3 (en) Use of no-signal cascade modulators and pharmaceutical composition
AU2002240395A1 (en) Pharmaceutical preparation for the treatment of topical wounds and ulcers
AU2002228391A1 (en) Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007530256

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2578212

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005279921

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005795551

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005279921

Country of ref document: AU

Date of ref document: 20050829

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005279921

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005795551

Country of ref document: EP